The Claim
Genetic variants in insulin signaling (INSR, IRS1, PPARG, TCF7L2), steroidogenesis (DENND1A, CYP11A1), and obesity-related genes (FTO, MC4R) are more prevalent or impactful in South Asian populations with polycystic ovary syndrome, leading to earlier onset and greater severity of cardiometabolic dysfunction.
What the research says
Not yet evaluated
We are still looking at what the research says.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In South Asian women with polycystic ovary syndrome, specific genetic variations in insulin, steroid, and obesity-related genes are more common or have stronger effects, resulting in earlier and more severe cardiometabolic problems.
See the scientific wording
The metabolic dysfunction in polycystic ovary syndrome (PCOS) is influenced by genetic variants in insulin signaling (INSR, IRS1, PPARG, TCF7L2), steroidogenesis (DENND1A, CYP11A1), and obesity-related genes (FTO, MC4R), which are more prevalent or impactful in South Asian populations, contributing to earlier and more severe cardiometabolic risk.
People with certain inherited gene changes have trouble using insulin properly, which causes their bodies to make too much male hormone and store fat in the wrong places like the liver and muscles. This leads to high blood sugar, high fat levels in the blood, and damage to the heart and blood vessels at an earlier age.
What the research says
1 studyThis study found that even thin South Asian women with PCOS often have serious problems processing sugar, which means their bodies are at high risk for diabetes and heart disease — even if they don’t look overweight. This matches the idea that their genes make them more vulnerable.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.